DoW Lung Cancer Translational Research Award
The FY26 Lung Cancer Research Program offers Translational Research Awards to move promising lung cancer discoveries toward clinical use. Projects must focus on at least one of the program’s FY26 lung cancer emphasis areas and may include advanced preclinical or correlative studies, or pilot clinical trials of novel interventions.
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
Dept. of the Army -- USAMRAA
-
DoW, Ovarian Cancer, Investigator-Initiated Research Award
Dept. of the Army -- USAMRAA
-
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
-
P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE)
National Institutes of Health ▸ National Cancer Institute
-
DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers